Latest Compliance News

Wide Open Agriculture Ltd has announced a Share Purchase Plan aiming to raise up to $500,000 through the issue of new shares and free-attaching options, pending shareholder approval. This capital raise complements a recent $2.6 million placement to support the company’s growth and production ramp-up.

Cardiex Limited has successfully raised $2.4 million through an institutional placement to boost manufacturing and commercial activities for its CONNEQT Pulse device.

Titan Minerals Limited has launched a transaction-specific prospectus offering 4 million new options to its underwriter, exercisable at A$0.70 and expiring in January 2027. The offer, which raises no immediate funds, could inject approximately A$2.8 million upon option exercise.

Lodestar Minerals has updated its investor presentation highlighting encouraging early drilling results from its Chilean IOCG and porphyry copper projects, alongside a clear roadmap for upcoming exploration activities.

Pursuit Minerals has withdrawn its previously stated 5,000 tonnes per annum lithium production target, clarifying it was an aspirational figure not compliant with ASX rules. The company urges investors to avoid relying on this figure for investment decisions.

Battery Age Minerals Ltd (ASX, BM8) has responded to an ASX price query following a notable jump in its share price and trading volume, attributing the activity to recent public communications and exploration progress.

Xstate Resources has disposed of its 20% stake in the Austrian Anshof project, eliminating liabilities and streamlining its portfolio ahead of a planned ASX re-listing and development of its Diona project in Queensland.

Xstate Resources has disposed of its 20% stake in the Austrian Anshof project, shedding liabilities and production to sharpen focus on its promising Diona project and upcoming ASX re-listing.

Elph Investments has raised and finalised its off-market takeover bid for Engenco Limited shares at $0.31 per share, applying to all shareholders including those who already accepted. This move signals a decisive step in the ongoing acquisition process.

OncoSil Medical has launched a Security Purchase Plan offering discounted shares and free options to eligible shareholders, aiming to accelerate commercialization of its pancreatic cancer treatment device.

Anax Metals has issued a detailed clarification on its recent $3.3 million convertible note placement with Mineral Development Partners, addressing inconsistencies in shareholder approval disclosures and announcing strengthened compliance measures.

Mayne Pharma rebuffs Cosette's claim of a material adverse change in their merger scheme and secures FDA clearance on regulatory concerns, maintaining its commitment to the deal's completion.